Therapeutic Potential of Essential Oils Against Ulcerative Colitis: A Review
DOI: https://doi.org/10.2147/jir.s461466
IF: 4.5
2024-05-31
Journal of Inflammation Research
Abstract:Jinkai Li, &ast Xiaofei Zhang, &ast Fei Luan, &ast Jiawei Duan, Junbo Zou, Jing Sun, Yajun Shi, Dongyan Guo, Changli Wang, Xiao Wang Key Laboratory of Basic and New Drug Research in Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiao Wang, Key Laboratory of Basic and New Drug Research in Chinese Medicine, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, People's Republic of China, Email Ulcerative colitis (UC) is a chronic non-sp ecific inflammatory disease of the colorectal mucosa. Researchers have associated UC onset with familial genetics, lifestyle behavior, inflammatory immune factors, intestinal microbiota, and the integrity of the intestinal mucosal barrier. The primary therapeutic interventions for UC consist of pharmacological management to control inflammation and promote mucosal healing and surgical interventions. The available drugs effectively control and decelerate the progression of UC in most patients; nonetheless, their long-term administration can exert adverse effects and influence the therapeutic effect. Plant essential oils (EOs) refer to a group of hydrophobic aromatic volatile substances. EOs have garnered considerable attention in both domestic and international research because of their anti-inflammatory, antibacterial, and antioxidant properties. They include peppermint, peppercorns, rosemary, and lavender, among others. Researchers have investigated the role of EOs in medicine and have elucidated their potential to mitigate the detrimental effects of UC through their anti-inflammatory, antioxidant, antidepressant, and anti-insomnia properties as well as their ability to regulate the intestinal flora. Furthermore, EOs exert minimal toxic adverse effects, further enhancing their appeal for therapeutic applications. However, these speculations are based on theoretical experiments, thereby warranting more clinical studies to confirm their effectiveness and safety. In this article, we aim to provide an overview of the advancements in utilizing natural medicine EOs for UC prevention and treatment. We will explore the potential pathogenesis of UC and examine the role of EOs therapy in basic research, quality stability, and management specification of inadequate EOs for UC treatment. We intend to offer novel insights into the use of EOs in UC prevention and management. Keywords: ulcerative colitis, essential oils, active ingredients, signaling pathway Graphical In the clinical setting, patients with ulcerative colitis (UC) present with symptoms, such as abdominal pain, diarrhea, and blood in stool. Often, these symptoms are accompanied by heightened oxidative stress and aggregated cellular inflammatory factors. Furthermore, the course of UC is typically prolonged and prone to recurrence; the long-term chronic inflammatory state increases the risk of developing colon cancer and associated diseases. 1 Data from surveys have indicated a strong correlation between UC prevalence and the level of economic development. Moreover, its incidence is rapidly increasing with the progress of social and economic development. For example, the prevalence of UC ranges from 5.50 to 24.30 per 10,000 globally. UC prevalence in developed countries, such as North America and Europe is approximately 24.30 per 10,000 and 19.20 per 10,000, respectively. By contrast, the prevalence in Asia and the Middle East is approximately 6.30 per 10,000. UC prevalence in mainland China is approximately 11.60 per 10,000, which may be underestimated. 2 Inflammatory bowel disease is more common in industrialized and Western countries; UC has a higher prevalence than Crohn's disease globally and in less developed countries. 3 Clinical treatment of UC is based on reducing inflammatory lesions, controlling symptoms, reducing recurrence, and controlling acute exacerbations. The drugs commonly used for UC treatment include aminosalicylic acid (salicylazosulfapyridine, mesalazine), immunosuppressants (azathioprine (AZA)), steroids (methylprednisolone), and biologics (adalimumab, infliximab, bifidobacteria, and bacillus coagulans). 4 However, these drugs are often expensive and display poor therapeutic efficacy. The long-term use of salicylates leads to adverse effects, such as nausea and vomiting. Excess glucocorticoid administration leads to Cushing's syndrome. Moreover, immunosuppressant use can cause bone marrow suppression and opportunistic infections. 5 Considering the adverse effects of traditional medicine use, researchers are investigating effective and inexpensive medicines. Flavonoids, terpenoids, and sulfur-containing compounds in medicinal plants have be -Abstract Truncated-
immunology